[{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 28000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 61, "title": "Chairman, CEO & President", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 6428574, "exercisedValue": 0, "unexercisedValue": 50993104}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 65, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 3007214, "exercisedValue": 0, "unexercisedValue": 1401880}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 61, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3327225, "exercisedValue": 0, "unexercisedValue": 7193319}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 57, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3174030, "exercisedValue": 0, "unexercisedValue": 4835902}, {"maxAge": 1, "name": "Dr. James E. Bradner M.D.", "age": 52, "title": "Executive Vice President of Research & Development", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 4095677, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 56, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 49, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 5, "shareHolderRightsRisk": 2, "overallRisk": 4, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 315.59, "open": 316.08, "dayLow": 314.0, "dayHigh": 321.42, "regularMarketPreviousClose": 315.59, "regularMarketOpen": 316.08, "regularMarketDayLow": 314.0, "regularMarketDayHigh": 321.42, "dividendRate": 9.52, "dividendYield": 2.97, "exDividendDate": 1763683200, "payoutRatio": 0.72620004, "fiveYearAvgDividendYield": 3.07, "beta": 0.461, "trailingPE": 24.744978, "forwardPE": 15.491051, "volume": 2663584, "regularMarketVolume": 2663584, "averageVolume": 2339460, "averageVolume10days": 2793970, "averageDailyVolume10Day": 2793970, "bid": 320.29, "ask": 320.34, "bidSize": 1, "askSize": 1, "marketCap": 172421513216, "fiftyTwoWeekLow": 253.3, "fiftyTwoWeekHigh": 335.88, "allTimeHigh": 346.85, "allTimeLow": 0.075521, "priceToSalesTrailing12Months": 4.793348, "fiftyDayAverage": 289.2446, "twoHundredDayAverage": 292.0001, "trailingAnnualDividendRate": 9.39, "trailingAnnualDividendYield": 0.029753797, "currency": "USD", "tradeable": false, "enterpriseValue": 217563512832, "profitMargins": 0.19474001, "floatShares": 537112930, "sharesOutstanding": 538480671, "sharesShort": 11478293, "sharesShortPriorMonth": 13202457, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.021300001, "heldPercentInsiders": 0.00214, "heldPercentInstitutions": 0.83621, "shortRatio": 4.23, "shortPercentOfFloat": 0.0214, "impliedSharesOutstanding": 538480671, "bookValue": 17.863, "priceToBook": 17.92532, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 0.136, "netIncomeToCommon": 7005000192, "trailingEps": 12.94, "forwardEps": 20.67, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.048, "enterpriseToEbitda": 13.201, "52WeekChange": -0.019328177, "SandP52WeekChange": 0.1198014, "lastDividendValue": 2.38, "lastDividendDate": 1755820800, "quoteType": "EQUITY", "currentPrice": 320.2, "targetHighPrice": 400.0, "targetLowPrice": 180.0, "targetMeanPrice": 312.34076, "targetMedianPrice": 315.0, "recommendationMean": 2.41935, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 9445000192, "totalCashPerShare": 17.54, "ebitda": 16481000448, "totalDebt": 54586998784, "quickRatio": 0.823, "currentRatio": 1.28, "totalRevenue": 35970998272, "debtToEquity": 567.491, "revenuePerShare": 66.892, "returnOnAssets": 0.07706, "returnOnEquity": 0.8171, "grossProfits": 25198000128, "freeCashflow": 11408624640, "operatingCashflow": 13125999616, "earningsGrowth": 0.136, "revenueGrowth": 0.124, "grossMargins": 0.70051, "ebitdaMargins": 0.45817003, "operatingMargins": 0.34153, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [{"header": "Dividend", "message": "AMGN announced a cash dividend of 2.38 with an ex-date of Nov. 21, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1763701200000, "amount": "2.38"}}], "postMarketTime": 1762563041, "regularMarketTime": 1762549202, "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.46076, "regularMarketPrice": 320.2, "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": 12.94, "epsForward": 20.67, "epsCurrentYear": 21.18017, "priceEpsCurrentYear": 15.117915, "fiftyDayAverageChange": 30.955414, "fiftyDayAverageChangePercent": 0.10702158, "twoHundredDayAverageChange": 28.19992, "twoHundredDayAverageChangePercent": 0.096575044, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "postMarketChangePercent": 0.0, "postMarketPrice": 320.2, "postMarketChange": 0.0, "regularMarketChange": 4.61002, "regularMarketDayRange": "314.0 - 321.42", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2339460, "fiftyTwoWeekLowChange": 66.90001, "fiftyTwoWeekLowChangePercent": 0.26411372, "fiftyTwoWeekRange": "253.3 - 335.88", "fiftyTwoWeekHighChange": -15.679993, "fiftyTwoWeekHighChangePercent": -0.046683315, "fiftyTwoWeekChangePercent": -1.9328177, "dividendDate": 1757635200, "earningsTimestamp": 1762290000, "earningsTimestampStart": 1762290000, "earningsTimestampEnd": 1762290000, "earningsCallTimestampStart": 1762291800, "earningsCallTimestampEnd": 1762291800, "isEarningsDateEstimate": false, "displayName": "Amgen", "trailingPegRatio": 0.9577, "__fetch_time": "2025-11-08"}]